Oncolytics Biotech (ONCY) Treasury Shares (2023 - 2025)

Oncolytics Biotech (ONCY) has 3 years of Treasury Shares data on file, last reported at $497842.0 in Q4 2025.

• On a quarterly basis, Treasury Shares fell 37.82% year-over-year to $497842.0 in Q4 2025; TTM through Dec 2025 was $497842.0, a 37.82% decrease from a year earlier, with the FY2025 full-year figure at $497842.0, down 39.06% from the prior year.
• Treasury Shares for Q4 2025 stood at $497842.0, down from $800684.4 in the prior quarter.
• Over the last five years, Treasury Shares for ONCY reached as high as $800684.4 in Q4 2024 and fell as low as $292668.3 in Q4 2023.
• Historically, Treasury Shares has averaged $530398.3 across 3 years, with a median of $497842.0 in 2025.
• Across the five-year window, Treasury Shares surged 173.58% in 2024 and sank 37.82% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $292668.3 in 2023, then jumped by 173.58% to $800684.4 in 2024, then sank by 37.82% to $497842.0 in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $497842.0 in Q4 2025, $800684.4 in Q4 2024, and $292668.3 in Q4 2023.